Cargando…

Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review

Hepatocellular carcinoma (HCC) has a poor prognosis due to its asymptomatic onset and susceptibility to metastasis. The survival of patients with advanced HCC is 6–12 months. As a first-line medicine for the control of hepatitis B virus, interferon (IFN) is also capable of inhibiting tumor growth an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fang, Lv, Hongmin, Li, Yan, Han, Tao, Liu, Hui, Jia, Kefeng, Liu, Fang, Gao, Yanying, Wang, Fengmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096095/ https://www.ncbi.nlm.nih.gov/pubmed/30127887 http://dx.doi.org/10.3892/ol.2018.9033

Ejemplares similares

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Interferon and interferon-stimulated genes in HBV treatment
por: Li, Qirong, et al.
Publicado: (2022)

Retracted Article: MicroRNA-1271 modulates hepatitis B virus replication, cell proliferation and apoptosis in hepatitis B virus-related hepatocellular carcinoma by targeting SIRT1
por: Tang, Fei, et al.
Publicado: (2019)

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
por: Han, Ji Eun, et al.
Publicado: (2021)

Chances for cure in chronic HBV/HDV coinfection
por: Iliescu, Gabriela, et al.
Publicado: (2014)

SLAMF6/Ly108 promotes the development of hepatocellular carcinoma via facilitating macrophage M2 polarization
por: Meng, Qi, et al.
Publicado: (2022)

HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure
por: Moini, Maryam, et al.
Publicado: (2022)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Complete genome sequence of Bacteroides helcogenes type strain (P 36-108(T))
por: Pati, Amrita, et al.
Publicado: (2011)

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
por: Wang, Hui, et al.
Publicado: (2014)

R108
por: CERN PhotoLab
Publicado: (1976)

At R108
por: CERN PhotoLab
Publicado: (1977)

At R108
por: CERN PhotoLab
Publicado: (1977)

At R108
por: CERN PhotoLab
Publicado: (1977)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

Editorial: Interferon and its antiviral effect in response to HBV infection
por: Song, Hongxiao, et al.
Publicado: (2023)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

R108 set-up, Gregoire Kantardjan
por: CERN PhotoLab
Publicado: (1976)

Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2017)

Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
por: Yang, Yu-Chan, et al.
Publicado: (2021)

Drug Discovery Study Aimed at a Functional Cure for HBV
por: Watanabe, Takehisa, et al.
Publicado: (2022)

Predictive factors of response to interferon in chronic HBV hepatitis
por: Popescu, Cristina, et al.
Publicado: (2014)

Darmstadt: Element 108
Publicado: (1984)

Darmstadt : Elément 108
Publicado: (1984)

Memorandum: Experiment S 108
por: CERN. Geneva, et al.
Publicado: (1971)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
por: Wang, Xiaomei, et al.
Publicado: (2021)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma
por: Lv, Jingzhu, et al.
Publicado: (2017)

Hepatocellular Carcinoma with Distant Metastasis Cured by 20-Day Sorafenib Treatment
por: Kim, Seok Bae
Publicado: (2021)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018)

Interferon-stimulated Gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma
por: Li, Chong, et al.
Publicado: (2014)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

128 Cure of HBV infection: can APOBEC3 deaminases mediate it?
por: Protzer, Ulrike
Publicado: (2014)

Fine‐Tuning TLR‐7‐Based Therapy for Functional HBV Cure
por: Bertoletti, Antonio, et al.
Publicado: (2019)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_81h0djtef8kvb87fn5a6ljpg6v